Hostname: page-component-76fb5796d-2lccl Total loading time: 0 Render date: 2024-04-26T08:28:50.328Z Has data issue: false hasContentIssue false

Laparoscopic donor nephrectomy – postoperative pain treatment

Published online by Cambridge University Press:  01 July 2008

Z. Jankovic*
Affiliation:
Department of Anaesthesia, St James’s University Hospital, Leeds, UK
L. Eyre
Affiliation:
Department of Anaesthesia, St James’s University Hospital, Leeds, UK
M. Kocarev
Affiliation:
Department of Anaesthesia, St James’s University Hospital, Leeds, UK
*
Correspondence to: Zorica Jankovic, Department of Anaesthesia, St James’s University Hospital, Beckett Street, Leeds LS9 7TF, UK. E-mail: Zorica.Jankovic@leedsth.nhs.uk; Tel: +44 113 2065789; Fax: +44 113 2064141

Abstract

Type
Correspondence
Copyright
Copyright © European Society of Anaesthesiology 2008

EDITOR:

Since the first reports of laparoscopic donor nephrectomy (LDN) two decades ago, it has become a routine surgical procedure. Most publications favour the laparoscopic procedure in terms of better pain control, faster recovery, less fatigue and better quality of life of the donor compared with mini-incision open donor nephrectomy (ODN). However, both procedures have equal safety and graft function.

When LDN was introduced in our hospital 3 yr ago, a literature search confirmed that LDN was less painful than ODN (i.e. postoperative morphine consumption decreased from 123.6 ± 88.0 mg for ODN to 24.4 ± 14.8 mg for LDN) [Reference Ratner, Kavoussi and Sroka1]. Consequently, we abandoned epidural analgesia for all donor nephrectomies and used a standard multimodal approach for postoperative pain treatment: morphine patient-controlled analgesia (PCA) as a first-line analgesic, combined with paracetamol and non-steroidal anti-inflammatory drugs (NSAIDs) as second-line analgesics.

Two years later, we undertook a retrospective review involving 58 donors: 19 intraperitoneal laparoscopic, 38 open and one laparoscopic converted into open. This review has demonstrated that morphine requirements in both groups were similar. The median dose of administered PCA morphine was 68 mg in the LDN group and 69 mg in the mini-incision ODN group. The difference was not significant (t-test, P > 0.05). the overall duration of use of morphine PCA was 42 h, and it was similar for both the groups (LDN vs. ODN, 47 vs. 40.5 h). The pain level was measured with a standard categorical scale (0–4), and the highest level of pain score at each day was recorded for the study. Of the patients, 38% had the highest score 1, 37.9% had score 2 and 27.6% had score 3. There were no significant differences in the pain scores between patients who underwent LDN and ODN (χ 2-test, P > 0.05). Although NSAIDs had been prescribed to all patients, they were used in only 40% of patients, and paracetamol was used regularly. Our results were different from a recently published randomized controlled study from The Netherlands, where it was found that the morphine requirements of the patients in LDN group were less compared with the mini-incision ODN group [Reference Kok, Lind and Hansson2]. The median morphine requirements in the LDN group were 16 mg (0–93) compared with 25 mg (1–107) in the ODN group, which was highly significant [Reference Kok, Lind and Hansson2]. Other studies also reported less or no opioid requirement following LDN. A study from the USA showed that 290 LDN had good pain control with oral medication when they used preoperative bowel rest and ketorolac as a bolus every 6 h [Reference Breda, Bui, Liao and Schulam3]. Their patients were discharged from hospital 24 h after surgery [Reference Breda, Bui, Liao and Schulam3]. Another retrospective analysis from Switzerland on 203 live kidney donors has shown that 87% retroperitoneoscopic donor nephrectomies had subcutaneous analgesia, only 11.7% had morphine PCA and 1.3% (one patient) had epidural analgesia. For ODN, 55.7% had an epidural, only 29.1% had PCA and even 15.2% had subcutaneous analgesia [Reference Bachmann, Wolff and Giannini4].

Finally, a randomized controlled study from Norway had 63 LDN and 59 ODN. With the addition of pro-paracetamol 2 g four times and ketorolac 30 mg three times on the day of surgery and on the first 2 postoperative days, their patients’ morphine consumption was 43.5 mg for LDN and 52.1 mg for ODN. Postoperative morphine consumption in this study was higher than in other studies, but still approximately 20 mg less than that in our study. There were differences between LDN and ODN, and pain scores were low: Pain score at rest was 1.0 for LDN and 1.1 for ODN [Reference Andersen, Mathisen and Oyen5].

The cause of postoperative pain after laparoscopic procedures is multifactorial. It may be associated with the insertion of ports or due to the low abdominal incision for the extraction of the kidney. Pelvic organ nociception or diaphragmatic irritation from residual pneumoperitoneum (which could cause shoulder-tip discomfort) may cause pain, too. Ureteric colic and urinary catheter discomfort may also contribute to the development of postoperative pain in these patients.

Presented data highlighted several main conclusions. Firstly, although we already knew that pain perception is very complex and is influenced by many factors, reported studies had shown that postoperative pain following LDN is perceived differently amongst different populations. Secondly, NSAIDs, initially banned in this group of patients because of potential renal damage, have a significant role in decreased opioid consumption and early mobilization with minimal side-effects in well-hydrated laparoscopic kidney donors. Thirdly, surgical technique has implications on postoperative pain perception: our patients had intraperitoneal laparoscopic surgery, while low morphine consumption has been reported in retroperitoneal surgery. The future of postoperative pain treatment in laparoscopic LDN is in furthering the multimodal approach, including regional techniques like paravertebral block, retroperitoneal surgical approach and bowel rest.

References

1.Ratner, LE, Kavoussi, LR, Sroka, M et al. Laparoscopic assisted live donor nephrectomy – a comparison with the open approach. Transplantation 1997; 63: 229233.CrossRefGoogle ScholarPubMed
2.Kok, NF, Lind, MY, Hansson, BM et al. Comparison of laparoscopic and mini incision open donor nephrectomy: single blind, randomised controlled clinical trial. BMJ 2006; 333: 221.CrossRefGoogle ScholarPubMed
3.Breda, A, Bui, MH, Liao, JC, Schulam, PG. Association of bowel rest and ketorolac analgesia with short hospital stay after laparoscopic donor nephrectomy. Urology 2007; 69: 828831.CrossRefGoogle ScholarPubMed
4.Bachmann, A, Wolff, T, Giannini, O et al. How painful is donor nephrectomy? Retrospective analysis of early pain and pain management in open versus laparoscopic versus retroperitoneoscopic nephrectomy. Transplantation 2006; 81: 17351738.CrossRefGoogle ScholarPubMed
5.Andersen, MH, Mathisen, L, Oyen, O et al. Postoperative pain and convalescence in living kidney donors-laparoscopic versus open donor nephrectomy: a randomized study. Am J Transplant 2006; 6: 14381443.Google Scholar